231 related articles for article (PubMed ID: 34121659)
1. Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer.
Inoue Y; Nikolic A; Farnsworth D; Shi R; Johnson FD; Liu A; Ladanyi M; Somwar R; Gallo M; Lockwood WW
Elife; 2021 Jun; 10():. PubMed ID: 34121659
[TBL] [Abstract][Full Text] [Related]
2. COP1/DET1/ETS axis regulates ERK transcriptome and sensitivity to MAPK inhibitors.
Xie Y; Cao Z; Wong EW; Guan Y; Ma W; Zhang JQ; Walczak EG; Murphy D; Ran L; Sirota I; Wang S; Shukla S; Gao D; Knott SR; Chang K; Leu J; Wongvipat J; Antonescu CR; Hannon G; Chi P; Chen Y
J Clin Invest; 2018 Apr; 128(4):1442-1457. PubMed ID: 29360641
[TBL] [Abstract][Full Text] [Related]
3. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.
Phuchareon J; McCormick F; Eisele DW; Tetsu O
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3855-63. PubMed ID: 26150526
[TBL] [Abstract][Full Text] [Related]
4. Erk/MAP kinase signaling pathway and neuroendocrine differentiation of non-small-cell lung cancer.
Chen Y; Nowak I; Huang J; Keng PC; Sun H; Xu H; Wei G; Lee SO
J Thorac Oncol; 2014 Jan; 9(1):50-8. PubMed ID: 24346093
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer.
Sunaga N; Kaira K; Imai H; Shimizu K; Nakano T; Shames DS; Girard L; Soh J; Sato M; Iwasaki Y; Ishizuka T; Gazdar AF; Minna JD; Mori M
Oncogene; 2013 Aug; 32(34):4034-42. PubMed ID: 22964644
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
Wan J; Wu W
J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
[TBL] [Abstract][Full Text] [Related]
7. ARHGEF19 regulates MAPK/ERK signaling and promotes the progression of small cell lung cancer.
Wang Z; Kan G; Sheng C; Yao C; Mao Y; Chen S
Biochem Biophys Res Commun; 2020 Dec; 533(4):792-799. PubMed ID: 32993957
[TBL] [Abstract][Full Text] [Related]
8. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer ETS rearrangements switch a cell migration gene expression program from RAS/ERK to PI3K/AKT regulation.
Selvaraj N; Budka JA; Ferris MW; Jerde TJ; Hollenhorst PC
Mol Cancer; 2014 Mar; 13():61. PubMed ID: 24642271
[TBL] [Abstract][Full Text] [Related]
10. Distinct dependencies on receptor tyrosine kinases in the regulation of MAPK signaling between BRAF V600E and non-V600E mutant lung cancers.
Kotani H; Adachi Y; Kitai H; Tomida S; Bando H; Faber AC; Yoshino T; Voon DC; Yano S; Ebi H
Oncogene; 2018 Mar; 37(13):1775-1787. PubMed ID: 29348459
[TBL] [Abstract][Full Text] [Related]
11. ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells.
Plotnik JP; Budka JA; Ferris MW; Hollenhorst PC
Nucleic Acids Res; 2014 Oct; 42(19):11928-40. PubMed ID: 25294825
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung Cancer.
Kitai H; Ebi H; Tomida S; Floros KV; Kotani H; Adachi Y; Oizumi S; Nishimura M; Faber AC; Yano S
Cancer Discov; 2016 Jul; 6(7):754-69. PubMed ID: 27154822
[TBL] [Abstract][Full Text] [Related]
13. Ras/MAPK signaling modulates VEGFR-3 expression through Ets-mediated p300 recruitment and histone acetylation on the Vegfr3 gene in lymphatic endothelial cells.
Ichise T; Yoshida N; Ichise H
PLoS One; 2012; 7(12):e51639. PubMed ID: 23284731
[TBL] [Abstract][Full Text] [Related]
14. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
15. Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancer.
Watanabe S; Hayashi H; Haratani K; Shimizu S; Tanizaki J; Sakai K; Kawakami H; Yonesaka K; Tsurutani J; Togashi Y; Nishio K; Ito A; Nakagawa K
Cancer Sci; 2019 Jan; 110(1):52-60. PubMed ID: 30390416
[TBL] [Abstract][Full Text] [Related]
16. Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers.
Cheung HW; Du J; Boehm JS; He F; Weir BA; Wang X; Butaney M; Sequist LV; Luo B; Engelman JA; Root DE; Meyerson M; Golub TR; Jänne PA; Hahn WC
Cancer Discov; 2011 Dec; 1(7):608-25. PubMed ID: 22586683
[TBL] [Abstract][Full Text] [Related]
17. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.
Dong QZ; Wang Y; Tang ZP; Fu L; Li QC; Wang ED; Wang EH
Am J Pathol; 2013 Mar; 182(3):954-64. PubMed ID: 23306155
[TBL] [Abstract][Full Text] [Related]
18. MEK inhibition remodels the active chromatin landscape and induces SOX10 genomic recruitment in BRAF(V600E) mutant melanoma cells.
Fufa TD; Baxter LL; Wedel JC; Gildea DE; ; Loftus SK; Pavan WJ
Epigenetics Chromatin; 2019 Aug; 12(1):50. PubMed ID: 31399133
[TBL] [Abstract][Full Text] [Related]
19. The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells.
Hoang VT; Nyswaner K; Torres-Ayuso P; Brognard J
J Biol Chem; 2020 Jun; 295(25):8470-8479. PubMed ID: 32358059
[TBL] [Abstract][Full Text] [Related]
20. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]